Firstly, although lucanthone- and combination- treated tumors significantly increased CD8a + cytotoxic T-cells, both within the tumor core and at the periphery of the tumor, MDI-2268-treated tumors showed the greatest increase in this cell type (Fig. 7A-C). This evidence concerns the gene CD8A and neoplasm.